# Efficacy and Tolerability of Erenumab in Patients With Trigeminal Neuralgia

> **NCT04054024** · PHASE2 · UNKNOWN · sponsor: **Danish Headache Center** · enrollment: 80 (estimated)

## Conditions studied

- Trigeminal Neuralgia

## Interventions

- **DRUG:** Erenumab
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT04054024
- **Lead sponsor:** Danish Headache Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-28
- **Primary completion:** 2021-10
- **Final completion:** 2021-10-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2019-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04054024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04054024, "Efficacy and Tolerability of Erenumab in Patients With Trigeminal Neuralgia". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT04054024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*